COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management
Editat de Brian C. Case, Ron Waksmanen Limba Engleză Paperback – 25 oct 2024
This is the perfect reference for basic and clinical researchers in cardiovascular medicine as well as practicing clinical cardiologists who are dealing with COVID-19 patients with cardiac involvement.
- Explains the pathophysiology, clinical manifestations, diagnostic approach, treatment options, and clinical outcomes of patients presenting with COVID-19 and cardiac involvement
- Elucidates new and emerging options to treat this disease process
- Provides concise, well validated, published data available in one single resource
Preț: 728.51 lei
Preț vechi: 960.21 lei
-24% Nou
Puncte Express: 1093
Preț estimativ în valută:
139.41€ • 146.63$ • 116.48£
139.41€ • 146.63$ • 116.48£
Carte disponibilă
Livrare economică 11-25 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443140013
ISBN-10: 0443140014
Pagini: 342
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443140014
Pagini: 342
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
1. Foreword
2. Introduction/Epidemiology
3. Pathophysiology of COVID-19
4. Risk Factors/Special Populations
5. Pathophysiology of COVID-19 and the Heart
6. Cardiac Clinical Manifestation
7. Non-Invasive Diagnostic Evaluation
8. Invasive Diagnostic Evaluation
9. Acute and Long-Term Treatment Options
10. Acute Clinical Outcome/Prognosis
11. Long Term Clinical Outcomes/Prognosis
12. Impact of COVID-19 on Heart Failure Patients and Valvular Heart Patients.
13. Emerging Therapeutic Options
14. The Role of COVID-19 Vaccine
15. Prologue
2. Introduction/Epidemiology
3. Pathophysiology of COVID-19
4. Risk Factors/Special Populations
5. Pathophysiology of COVID-19 and the Heart
6. Cardiac Clinical Manifestation
7. Non-Invasive Diagnostic Evaluation
8. Invasive Diagnostic Evaluation
9. Acute and Long-Term Treatment Options
10. Acute Clinical Outcome/Prognosis
11. Long Term Clinical Outcomes/Prognosis
12. Impact of COVID-19 on Heart Failure Patients and Valvular Heart Patients.
13. Emerging Therapeutic Options
14. The Role of COVID-19 Vaccine
15. Prologue